product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
MARK2 Antibody
catalog :
9118
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot, proximity ligation assay
more info or order :
Cell Signaling Technology product webpage
citations: 1
Published Application/Species/Sample/DilutionReference
  • proximity ligation assay; mouse; fig 3
Dumont N, Wang Y, von Maltzahn J, Pasut A, Bentzinger C, Brun C, et al. Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med. 2015;21:1455-63 pubmed publisher
product information
SKU :
9118S
Product-Name :
MARK2 Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, (Mk)
Applications :
Western blot
Product-Category :
Cytoskeletal Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
78, 82
Host :
Rabbit
Target :
MARK2
Primary-Protein :
MARK2
Alt-Names :
ELKL motif kinase 1,EMK-1,EMK1,MAP/microtubule affinity-regulating kinase 2,MARK2,MGC99619,PAR-1,PAR1 homolog,Par1b,Ser/Thr protein kinase PAR-1B,Serine/threonine-protein kinase MARK2,serine/threonine protein kinase EMK
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.